Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
about
NephroCheck data compared to serum creatinine in various clinical settingsNew symmetrically esterified m-bromobenzyl non-aminobisphosphonates inhibited breast cancer growth and metastases.New dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari.Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.Antibiotic effects on bacterial profile in osteonecrosis of the jawBisphosphonates in Breast Cancer Patients with Bone MetastasesClinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonatesDose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitroPathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats.Zoledronic acid: an unending tale for an antiresorptive agent.Design and Biological Evaluation of Delivery Systems Containing BisphosphonatesBisphosphonate-related osteonecrosis of the jaw: a review of the literature.Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering.Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis.Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces.Wound healing protein profiles in the postoperative exudate of bisphosphonate-related osteonecrosis of mandible.Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole.Osteonecrosis of the posterior mandible after implant insertion: a clinical and histological case report.Effects of locally administered tiludronic acid on experimental periodontitis in rats.Relevance of surgical management of patients affected by bisphosphonate-associated osteonecrosis of the jaws. A prospective clinical and radiological study.Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.Comparison of effects of zoledronic acid and clodronate on the bone structure: imaginological and histomorphometrical study in vivo.Effects of Local Administration of Tiludronic Acid on Experimental Periodontitis in Diabetic Rats.Bisphosphonate-related osteonecrosis of the jaws: analysis of a case series at a dental school.Surgical treatment of bisphosphonate-related osteonecrosis of the jaws with the use of buccal fat pad: case report.
P2860
Q31031264-7E104768-3F99-4CA0-AC9D-FBB28AC4C64EQ33415020-66E893A9-B2FC-4E85-B12E-E4C509AF2D3CQ33796816-9199C53F-C16C-4D7C-90FD-6F46ADF8176FQ33989948-DAE5091A-3A17-4120-B551-DA9B12AB191DQ34007581-945B58D5-8375-40E9-94D0-5A23619BACEBQ35095548-ACB8EC97-658A-474D-BCF8-587F7DB57DF9Q35533455-FE62B85A-DAEF-4B1C-BE0A-A3C543438D92Q36390242-72CC643C-90A9-4FF2-944D-F56FD6636D8AQ37170651-B57F0903-F154-45FA-92E6-19914D906299Q37613671-DB666404-9874-455B-88D7-FBA2B080184AQ37650334-5F492717-2E67-411B-B4D1-17C275A00BD3Q37731222-3E845B2A-752A-4A4E-9F91-4865485B92F7Q38215499-75C438EB-2B9C-4F5D-8E6E-56B45FDCD7DDQ38367669-E6993397-6780-4BC2-B7DE-21427C230169Q38585389-4AF6139C-65C4-4464-A34E-77560B2CCDDAQ38688675-6B9D8209-D63C-4ADE-9378-19F26B47DEBAQ40159088-6C03A623-2568-4F24-9338-3D3840B8ECB9Q41684442-D67305C7-52D4-4001-8DEB-423797DE8F1EQ44468582-CDFD4388-5881-4298-ABF8-2E093CF47438Q44479944-D5C54751-2942-4C13-BFEC-1D6C1BCA5327Q46485942-F487C1FD-D169-4FD0-BBEC-5859BEFE3A03Q47727040-82517843-C162-45E4-9D2C-CD24FB881052Q48093177-128650F3-6C1E-48BE-99BD-98C908D962D5Q50071876-F43B9E04-D37A-4B61-834B-1C9D5E98522CQ50790498-2A558EE3-0B91-4EAE-8E50-0846F147FF28Q51838456-493F5FDA-87DD-4009-A5F9-36271B94AAAB
P2860
Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pathophysiology, risk factors ...... and non-aminobisphosphonates?
@en
type
label
Pathophysiology, risk factors ...... and non-aminobisphosphonates?
@en
prefLabel
Pathophysiology, risk factors ...... and non-aminobisphosphonates?
@en
P2093
P1476
Pathophysiology, risk factors ...... and non-aminobisphosphonates?
@en
P2093
Bilal Al-Nawas
Bodo Hoffmeister
Cesar Migliorati
Ignac Fogelman
Ingo J Diel
Joseph Gligorov
Kalervo Väänänen
Liisa Pylkkänen
Martin Pecherstorfer
Matti S Aapro
P304
P356
10.1016/J.CRITREVONC.2007.07.005
P577
2007-09-12T00:00:00Z